|
1
|
Dufrane D: Impact of age on human adipose
stem cells for bone tissue engineering. Cell Transplant.
26:1496–1504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weinand C, Neville CM, Weinberg E, Tabata
Y and Vacanti JP: Optimizing biomaterials for tissue engineering
human bone using mesenchymal stem cells. Plast Reconstr Surg.
137:854–863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertolo A, Mehr M, Janner-Jametti T,
Graumann U, Aebli N, Baur M, Ferguson SJ and Stoyanov JV: An in
vitro expansion score for tissue-engineering applications with
human bone marrow-derived mesenchymal stem cells. J Tissue Eng
Regen Med. 10:149–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alizadeh A, Moztarzadeh F, Ostad SN, Azami
M, Geramizadeh B, Hatam G, Bizari D, Tavangar SM, Vasei M and Ai J:
Synthesis of calcium phosphate-zirconia scaffold and human
endometrial adult stem cells for bone tissue engineering. Artif
Cells Nanomed Biotechnol. 44:66–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang P, Liu X, Zhao L, Weir MD, Sun J,
Chen W, Man Y and Xu HH: Bone tissue engineering via human induced
pluripotent, umbilical cord and bone marrow mesenchymal stem cells
in rat cranium. Acta Biomater. 18:236–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: Implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amini AR, Laurencin CT and Nukavarapu SP:
Bone tissue engineering: Recent advances and challenges. Crit Rev
Biomed Eng. 40:363–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oryan A, Alidadi S, Moshiri A and Maffulli
N: Bone regenerative medicine: Classic options, novel strategies,
and future directions. J Orthop Surg Res. 9:182014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oryan A, Kamali A, Moshiri A and Baghaban
Eslaminejad M: Role of mesenchymal stem cells in bone regenerative
medicine: What is the evidence? Cells Tissues Organs. 204:59–83.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tapp H, Hanley EN Jr, Patt JC and Gruber
HE: Adipose-derived stem cells: Characterization and current
application in orthopaedic tissue repair. Exp Biol Med (Maywood).
234:1–9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Caplan AI and Dennis JE: Mesenchymal stem
cells as trophic mediators. J Cell Biochem. 98:1076–1084. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Orbay H, Busse B, Leach JK and Sahar DE:
The effects of Adipose-derived stem cells differentiated into
endothelial cells and osteoblasts on healing of critical size
calvarial defects. J Craniofac Surg. 28:1874–1879. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Knippenberg M, Helder MN, Zandieh Doulabi
B, Wuisman PI and Klein-Nulend J: Osteogenesis versus
chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem
Biophys Res Commun. 342:902–908. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin Y, Zhang W, Liu Y, Zhang M, Xu L, Wu
Q, Zhang X, Zhu Z, Huang Q and Jiang X: rhPDGF-BB via ERK pathway
osteogenesis and adipogenesis balancing in ADSCs for critical-sized
calvarial defect repair. Tissue Eng Part A. 20:3303–3313. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lough DM, Chambers C, Germann G, Bueno R,
Reichensperger J, Swanson E, Dyer M, Cox L, Harrison C and
Neumeister MW: Regulation of ADSC Osteoinductive potential using
notch pathway inhibition and gene rescue: A Potential On/Off Switch
for clinical applications in bone formation and reconstructive
efforts. Plast Reconstr Surg. 138:642e–652e. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Hu C, Li J, Liu L, Jing W, Tang W,
Tian W and Long J: Effect of miR-26a-5p on the Wnt/Ca(2+) pathway
and osteogenic differentiation of mouse Adipose-derived mesenchymal
stem cells. Calcif Tissue Int. 99:174–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu X, Fu Y, Zhang X, Dai L, Zhu J, Bi Z,
Ao Y and Zhou C: Histone deacetylase inhibitor sodium butyrate
promotes the osteogenic differentiation of rat adipose-derived stem
cells. Dev Growth Differ. 56:206–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gersbach CA, Byers BA, Pavlath GK and
Garcia AJ: Runx2/Cbfa1 stimulates transdifferentiation of primary
skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp
Cell Res. 300:406–417. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee B, Thirunavukkarasu K, Zhou L, Pastore
L, Baldini A, Hecht J, Geoffroy V, Ducy P and Karsenty G: Missense
mutations abolishing DNA binding of the osteoblast-specific
transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat
Genet. 16:307–310. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Yang M, Lin L, Chen P, Ma KT,
Zhou CY and Ao YF: Runx2 overexpression enhances osteoblastic
differentiation and mineralization in adipose-derived stem cells in
vitro and in vivo. Calcif Tissue Int. 79:169–178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Basoli V, Santaniello S, Cruciani S,
Ginesu GC, Cossu ML, Delitala AP, Serra PA, Ventura C and Maioli M:
Melatonin and Vitamin D interfere with the adipogenic fate of
Adipose-derived stem cells. Int J Mol Sci. 18:E9812017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malhotra R, Singh L, Eng J and Raufman JP:
Exendin-4, a new peptide from Heloderma suspectum venom,
potentiates cholecystokinin-induced amylase release from rat
pancreatic acini. Regul Pept. 41:149–156. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eng J, Kleinman WA, Singh L, Singh G and
Raufman JP: Isolation and characterization of exendin-4, an
exendin-3 analogue, from Heloderma suspectum venom. Further
evidence for an exendin receptor on dispersed acini from guinea pig
pancreas. J Biol Chem. 267:7402–7405. 1992.PubMed/NCBI
|
|
24
|
Eng J: Exendin peptides. Mt Sinai J Med.
59:147–149. 1992.PubMed/NCBI
|
|
25
|
Edwards CM, Stanley SA, Davis R, Brynes
AE, Frost GS, Seal LJ, Ghatei MA and Bloom SR: Exendin-4 reduces
fasting and postprandial glucose and decreases energy intake in
healthy volunteers. Am J Physiol Endocrinol Metab. 281:E155–E161.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nielsen LL, Young AA and Parkes DG:
Pharmacology of exenatide (synthetic exendin-4): A potential
therapeutic for improved glycemic control of type 2 diabetes. Regul
Pept. 117:77–88. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamada C, Yamada Y, Tsukiyama K, Yamada K,
Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y and Inagaki
N: The murine glucagon-like peptide-1 receptor is essential for
control of bone resorption. Endocrinology. 149:574–579. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nuche-Berenguer B, Lozano D,
Gutierrez-Rojas I, Moreno P, Mariñoso ML, Esbrit P and
Villanueva-Peñacarrillo ML: GLP-1 and exendin-4 can reverse
hyperlipidic-related osteopenia. J Endocrinol. 209:203–210. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma X, Meng J, Jia M, Bi L, Zhou Y, Wang Y,
Hu J, He G and Luo X: Exendin-4, a glucagon-like peptide-1 receptor
agonist, prevents osteopenia by promoting bone formation and
suppressing bone resorption in aged ovariectomized rats. J Bone
Miner Res. 28:1641–1652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng Y, Su L, Zhong X, Guohong W, Xiao H,
Li Y and Xiu L: Exendin-4 promotes proliferation and
differentiation of MC3T3-E1 osteoblasts by MAPKs activation. J Mol
Endocrinol. 56:189–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He J, Wang C, Sun Y, Lu B, Cui J, Dong N,
Zhang M, Liu Y and Yu B: Exendin-4 protects bone marrow-derived
mesenchymal stem cells against oxygen/glucose and serum
deprivation-induced apoptosis through the activation of the
cAMP/PKA signaling pathway and the attenuation of ER stress. Int J
Mol Med. 37:889–900. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y,
Li M, Zhang H, Xue X, Hou Z, et al: Activation of GLP-1 receptor
promotes bone marrow stromal cell osteogenic differentiation
through β-Catenin. Stem Cell Reports. 6:579–591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen WR, Kimura K, Ishida M, Sugisawa H,
Kishikawa A, Shima K, Ogawa S, Qi J and Kitaura H: The
glucagon-like Peptide-1 receptor agonist Exendin-4 inhibits
lipopolysaccharide-induced osteoclast formation and bone resorption
via inhibition of TNF-α expression in macrophages. J Immunol Res.
2018:57836392018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Uusitalo H, Rantakokko J, Ahonen M, Jämsä
T, Tuukkanen J, KäHäri V, Vuorio E and Aro HT: A metaphyseal defect
model of the femur for studies of murine bone healing. Bone.
28:423–429. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin M, Liu R, Gozal D, Wead WB, Chapleau
MW, Wurster R and Cheng ZJ: Chronic intermittent hypoxia impairs
baroreflex control of heart rate but enhances heart rate responses
to vagal efferent stimulation in anesthetized mice. Am J Physiol
Heart Circ Physiol. 293:H997–H1006. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soranno DE, Rodell CB, Altmann C,
Duplantis J, Andres-Hernando A, Burdick JA and Faubel S: Delivery
of interleukin-10 via injectable hydrogels improves renal outcomes
and reduces systemic inflammation following ischemic acute kidney
injury in mice. Am J Physiol Renal Physiol. 311:F362–F372. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang N, Gao J, Jia M, Ma X, Lei Z, Da F,
Yan F, Zhang H, Zhou Y, Li M, et al: Exendin-4 induces bone marrow
stromal cells migration through bone marrow-derived macrophages
polarization via PKA-STAT3 signaling pathway. Cell Physiol Biochem.
44:1696–1714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
β-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roxburgh J, Metcalfe AD and Martin YH: The
effect of medium selection on adipose-derived stem cell expansion
and differentiation: Implications for application in regenerative
medicine. Cytotechnology. 68:957–967. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Simonet WS, Lacey DL, Dunstan CR, Kelley
M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et
al: Osteoprotegerin: A novel secreted protein involved in the
regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gerstenfeld LC and Shapiro FD: Expression
of bone-specific genes by hypertrophic chondrocytes: Implication of
the complex functions of the hypertrophic chondrocyte during
endochondral bone development. J Cell Biochem. 62:1–9. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Greep RO, Fischer CJ and Morse A: Alkaline
phosphatase in odontogenesis and osteogenesis and its histochemical
demonstration after demineralization. J Am Dent Assoc. 36:427–442.
1948. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nakashima K, Zhou X, Kunkel G, Zhang Z,
Deng JM, Behringer RR and de Crombrugghe B: The novel zinc
finger-containing transcription factor osterix is required for
osteoblast differentiation and bone formation. Cell. 108:17–29.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
McCarthy TL, Ji C, Chen Y, Kim KK, Imagawa
M, Ito Y and Centrella M: Runt domain factor (Runx)-dependent
effects on CCAAT/enhancer-binding protein delta expression and
activity in osteoblasts. J Biol Chem. 275:21746–21753. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Seo MH, Lee J, Hong SW, Rhee EJ, Park SE,
Park CY, Oh KW, Park SW and Lee WY: Exendin-4 inhibits hepatic
lipogenesis by increasing beta-catenin signaling. PLoS One.
11:e01669132016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu W, Yang Y, Yuan G, Zhu W, Ma D and Hu
S: Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces
Alzheimer disease-associated tau hyperphosphorylation in the
hippocampus of rats with type 2 diabetes. J Investig Med.
63:267–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hayes MR: Neuronal and intracellular
signaling pathways mediating GLP-1 energy balance and glycemic
effects. Physiol Behav. 106:413–416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mainil-Varlet P, Aigner T, Brittberg M,
Bullough P, Hollander A, Hunziker E, Kandel R, Nehrer S, Pritzker
K, Roberts S, et al: Histological assessment of cartilage repair: A
report by the Histology endpoint committee of the international
cartilage repair society (ICRS). J Bone Joint Surg Am. 85-A (Suppl
2):S45–S57. 2003. View Article : Google Scholar
|
|
50
|
Veronesi F, Maglio M, Tschon M, Aldini NN
and Fini M: Adipose-derived mesenchymal stem cells for cartilage
tissue engineering: State-of-the-art in in vivo studies. J Biomed
Mater Res A. 102:2448–2466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Di Bella C, Farlie P and Penington AJ:
Bone regeneration in a rabbit critical-sized skull defect using
autologous adipose-derived cells. Tissue Eng Part A. 14:483–490.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jeon O, Rhie JW, Kwon IK, Kim JH, Kim BS
and Lee SH: In vivo bone formation following transplantation of
human adipose-derived stromal cells that are not differentiated
osteogenically. Tissue Eng Part A. 14:1285–1294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jurgens WJ, Oedayrajsingh-Varma MJ, Helder
MN, Zandiehdoulabi B, Schouten TE, Kuik DJ, Ritt MJ and van
Milligen FJ: Effect of tissue-harvesting site on yield of stem
cells derived from adipose tissue: Implications for cell-based
therapies. Cell Tissue Res. 332:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Al-Salleeh F, Beatty MW, Reinhardt RA,
Petro TM and Crouch L: Human osteogenic protein-1 induces
osteogenic differentiation of adipose-derived stem cells harvested
from mice. Arch Oral Biol. 53:928–936. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ahn HH, Kim KS, Lee JH, Lee JY, Kim BS,
Lee IW, Chun HJ, Kim JH, Lee HB and Kim MS: In vivo osteogenic
differentiation of human adipose-derived stem cells in an
injectable in situ-forming gel scaffold. Tissue Eng Part A.
15:1821–1832. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Asserson DB, Orbay H and Sahar DE: Review
of the pathways involved in the osteogenic differentiation of
Adipose-derived stem cells. J Craniofac Surg. 30:703–708. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang H, Kot A, Lay YE, Fierro FA, Chen H,
Lane NE and Yao W: Acceleration of fracture healing by
overexpression of basic fibroblast growth factor in the mesenchymal
stromal cells. Stem Cells Transl Med. 6:1880–1893. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Deng Y, Guo T, Li J, Guo L, Gu P and Fan
X: Repair of calvarial bone defect using Jarid1a-knockdown bone
mesenchymal stem cells in rats. Tissue Eng Part A. 24:711–718.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xie Q, Wei W, Ruan J, Ding Y, Zhuang A, Bi
X, Sun H, Gu P, Wang Z and Fan X: Effects of miR-146a on the
osteogenesis of adipose-derived mesenchymal stem cells and bone
regeneration. Sci Rep. 7:428402017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Huang M, Qing Y, Shi Q, Cao Y and Song K:
miR-342-3p elevates osteogenic differentiation of umbilical cord
mesenchymal stem cells via inhibiting Sufu in vitro. Biochem
Biophys Res Commun. 491:571–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
